Kelvin P Lee MD
Professor, Medicine, SUNY Buffalo School of Medicine & Biomedical
Join to View Full Profile
1701 N Senate BlvdIndianapolis, IN 46202
Phone+1 888-484-3258
Fax+1 716-845-2993
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 1987 - 1990
University of ColoradoResidency, Internal Medicine, 1984 - 1987
University of Michigan Medical SchoolClass of 1984
Certifications & Licensure
FL State Medical License 1999 - 2026
NY State Medical License 2007 - 2026
IN State Medical License 2021 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma Start of enrollment: 2000 Jun 01
- Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia Start of enrollment: 2002 May 01
- Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia Start of enrollment: 2004 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 16 citationsVeterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study.Daniel W. Lin, Mei Chiung Shih, William J. Aronson, Joseph W. Basler, Tomasz M. Beer
European Urology. 2020-05-01 - 37 citationsInhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myelomaAnna Bianchi-Smiraglia, Archis Bagati, Emily E. Fink, Hayley C. Affronti, Brittany C. Lipchick
The Journal of Clinical Investigation. 2018-10-01 - 31 citationsNovel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.Jayakumar R. Nair, Justin Caserta, K Belko, T Howell, Gerald J. Fetterly
Leukemia. 2017-08-01
Press Mentions
IU School of Medicine Names First Walther Scholar in Psycho-OncologyApril 26th, 2022- Students Present Their Summer Research ProjectsSeptember 13th, 2021
- New IU Simon Comprehensive Cancer Center Director Lays Out His VisionApril 29th, 2021
- Join now to see all
Grant Support
- Multidisciplinary Approaches To Tumor ImmunologyNational Cancer Institute2007–2011
- Cd28-Mediated Regulation Of Multiple Myeloma Cell Proliferation And SurvivalNational Cancer Institute2007–2011
- Extramural Research Facility Construction Projects. Ros*National Center For Research Resources2010
- Program LeadersNational Cancer Institute2008
- Human Hematopoietic And Immune Cell BankNational Cancer Institute2006
- Arsenic Trioxide &Ascorbic Acid For Multiple MyelomaNational Cancer Institute2006
- Arsenic Trioxide &Ascorbic Acid For Multiple MyelomaNational Cancer Institute2002–2006
- Human Hematopoietic And Immune Cell BankNational Cancer Institute2002–2005
- Induced Leukemic Cell Differentiation To Dendritc CellNational Cancer Institute1999–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
